Boston Scientific Gets Small-Vessel Stent Approved

Boston Scientific announced that it has received FDA approval for the Taxus Express2 Atom drug-eluting stent system, which is the first drug-eluting stent designed for small coronary vessels. It is the first DES approved by FDA for use in vessels as small as 2.25 mm in diameter.

September 25, 2008

1 Min Read
Boston Scientific Gets Small-Vessel Stent Approved

The firm also got approval for the Taxus Express2 DES, which is indicated for treatment of in-stent restenosis in bare-metal stents.This gives Boston Scientific four DES models on the U.S. market, the most of any company. The other two are the original version of Taxus and Promus, the firm's version of Abbott's Xience V, originally developed by Guidant.UPDATE: Boston Scientific CEO Jim Tobin says he expects FDA approval of the firm's next-generation DES, Taxus Liberte, to come by the end of the year at the latest. The Express approvals are a sign that FDA is gradually lifting the "corporate warning letter" it levied against Boston Scientific in 2006, which had prevented the firm from introducing certain products.-- From PrecisionTalk.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like